BACATTACK

A stealth attack tool for preventing clinical drug resistance through a unique self-regenerating surface

 Coordinatore TEKNOLOGISK INSTITUT 

 Organization address address: GREGERSENSVEJ 1
city: TAASTRUP
postcode: 2630

contact info
Titolo: Dr.
Nome: Anne-Lise Høg
Cognome: Lejre
Email: send email
Telefono: +45 7220 3116

 Nazionalità Coordinatore Denmark [DK]
 Totale costo 3˙890˙118 €
 EC contributo 2˙990˙698 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2011-two-stage
 Funding Scheme CP-FP
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-01-01   -   2015-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    TEKNOLOGISK INSTITUT

 Organization address address: GREGERSENSVEJ 1
city: TAASTRUP
postcode: 2630

contact info
Titolo: Dr.
Nome: Anne-Lise Høg
Cognome: Lejre
Email: send email
Telefono: +45 7220 3116

DK (TAASTRUP) coordinator 823˙780.00
2    BACTIGUARD AB

 Organization address address: BIBLIOTEKSGATAN 25
city: STOCKHOLM
postcode: 10242

contact info
Titolo: Dr.
Nome: Mattias
Cognome: Ohrlander
Email: send email
Telefono: +46 84 40 58 80
Fax: +46 84 40 58 90

SE (STOCKHOLM) participant 539˙200.00
3    BIOMODICS APS

 Organization address address: STENGARDS ALLE 31A
city: KGS LYNGBY
postcode: 2800

contact info
Titolo: Dr.
Nome: Peter
Cognome: Thomsen
Email: send email
Telefono: +45 61 66 66 19
Fax: +45 33 23 20 48

DK (KGS LYNGBY) participant 475˙740.00
4    LABORATOIRE D'EVALUTION DES MATERIELS IMPLANTABLES SA

 Organization address city: MARTILLAC
postcode: 33650

contact info
Titolo: Mr.
Nome: Pierre
Cognome: Gonfrier
Email: send email
Telefono: +33 55 66 49 000
Fax: +33 55 66 49 002

FR (MARTILLAC) participant 367˙564.00
5    ST GEORGE'S HOSPITAL MEDICAL SCHOOL

 Organization address address: Cranmer Terrace
city: LONDON
postcode: SW17 0RE

contact info
Titolo: Prof.
Nome: Anthony
Cognome: Coates
Email: send email
Telefono: +44 20 87 25 57 25

UK (LONDON) participant 338˙881.00
6    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Ms.
Nome: Talia
Cognome: Tzahor
Email: send email
Telefono: +972 8 934 4026
Fax: +972 8 934 4165

IL (REHOVOT) participant 316˙550.00
7    NOVOZYMES A/S

 Organization address address: Krogshoejvej 36
city: BAGSVAERD
postcode: 2880

contact info
Titolo: Ms.
Nome: Nina
Cognome: Eckert Busgaard
Email: send email
Telefono: +45 4446 0794
Fax: +45 4446 9999

DK (BAGSVAERD) participant 128˙983.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

surface    effect    resistance    release    drug    antimicrobial    clinical    biofilm    infections    patients    treatment   

 Obiettivo del progetto (Objective)

'Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large doses of systemically applied drugs. There is a high risk of recurring infections and biofilm formation for patients dependent on long term in-dwelling catheters and the extended dependency on antibiotics result in clinical drug resistance. We present a new tool for minimizing drug resistance by upgrading existing and future medical devices through a unique self-regenerating surface that prevents biofilm formation by a two-fold stealth attack mechanism. This will be achieved by an interpenetrating polymer network (IPN) that allows for long term release of a range of antimicrobial strategies, such as antimicrobial peptides (AMPs) . The IPNs contain hydrogels where the AMP is stored until the release starts at the insertion of the device with an expected long-term effect. The first line of defence will be a fixed galvanic noble metal alloy coating that will prevent bacteria from colonizing the surface. Local and site-specific treatment with long term effect instead of systemic treatment implies improved patient management and citizen well-fare.'

Altri progetti dello stesso programma (FP7-HEALTH)

NEURINOX (2012)

NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies

Read More  

INNOVALIV (2011)

Innovative strategies to generate human hepatocytes for treatment of metabolic Liver diseases: Tools for personalized cell therapy

Read More  

PANACEA (2009)

Quantitative pathway analysis of natural variation in complex disease signaling in C. elegans

Read More